Gavin Hill

Gavin Fenton Hill is currently Director at Scienta Scientific AB; Director at Oxford Instruments Overseas Holdings Ltd., Oxford Instruments AFM Ltd., Oxford Instruments Overseas Holdings 2008 Ltd., Oxford Instruments Holdings Europe Ltd., Oxford Instruments Industrial Products Ltd., Oxford Instruments Industrial Products Holdings Ltd., Oxford Instruments NanoTechnology Tools Ltd., Oxford Instruments NanoTechnology Tools Holdings Ltd., and Oxford Instruments UK 2013 Ltd.; Non-Executive Director at BMT Group Ltd. and Eurofins Scientific SE; Independent Non-Executive Director at Forterra Plc; and Associate Member at The Association of Corporate Treasurers.
Former roles include Chief Financial Officer & Executive Director at Oxford Instruments Plc from 2016 to 2025; Executive Director & Group Finance Director at Synergy Health Ltd. from 2012 to 2016; Finance Director at Serco Group Plc from 2002 to 2010; Head-Finance & Corporate Treasury at AstraZeneca PLC from 1994 to 2002; Head-Finance & Corporate Treasury at Syngenta AG from 2000 to 2002; Co-Managing Director at Oxford Instruments GmbH; Director at Andor Technology Ltd.; and Associate Member at ACT 2013 Ltd. Education includes an undergraduate degree from The University of Exeter, conferred in 1990.